Sales and Marketing

Showing 15 posts of 11528 posts found.

Amgen and Immatics enter $1bn immuno-oncology partnership

January 9, 2017 Research and Development, Sales and Marketing Amgen, immatics, immunotherapy

Amgen has announced it is to join forces with cancer immunotherapy biotech Immatics Biotechnologies in a partnership potentially worth over …

Merrimack sells off drug for $1 billion and cuts workforce by 80%

January 9, 2017 Sales and Marketing Onivyde, ipsen, merrimack

Ipsen has announced the agreement to acquire oncology assets from Merrimack Pharmaceuticals, most notably the pancreatic cancer drug Onivyde, in …

Roche’s Tecentriq scores another bladder cancer Priority Review

January 9, 2017 Sales and Marketing Roche, bladder cancer, tecentriq

Roche has announced that its immunotherapy drug Tecenetriq (atezolizumab) has been awarded Priority Review by the FDA for the treatment …

Targovax promotes new CFO

January 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targovax

Erik Digman Wiklund has been named as the new chief financial officer (CFO) of Norwegian biotech Targovax, replacing Oystein Soug …

Pfizer announce positive results for Humira biosimilar

January 6, 2017 Medical Communications, Research and Development, Sales and Marketing Humira, Pfizer, biosimilar

Pfizer has released the successful Phase 3 results to its biosimilar to AbbVie’s blockbuster Humira, meeting its primary endpoint in …

Novartis and Ionis enter $1bn cardiovascular drug deal

January 6, 2017 Medical Communications, Research and Development, Sales and Marketing Akcea, Akcea Therapeutics, Ionis, Ionis Pharmaceuticals, cardiovascular

Ionis Pharmaceuticals and one of its wholly-owned subsidiaries Akcea Therapeutics have entered into a partnership with Novartis worth potentially more …

AstraZeneca acquires biotech’s unique antithrombotic drug

January 5, 2017 Medical Communications, Sales and Marketing APT, AstraZeneca, acquisition

AstraZeneca has announced that it has entered into a research collaboration, option and asset purchase agreement with APT Therapeutics, a …

Morning sickness pill scientific backing called into question

January 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diclectin, Diclegis, Duchesnay, FDA, kim kardashian, morning sickness

Many women suffer from morning sickness during the early stages of pregnancy and some suffer from hyperemesis gravidarum, acute morning …

Philippine FDA orders Sanofi to pull dengue vaccine ads

January 5, 2017 Medical Communications, Sales and Marketing Philippines, Sanofi, Vaccine, dengue, virus

Sanofi has suffered a major blow to its dengue immunisation programme in the Philippines after it was requested the company …

FDA steps up fight against superbugs with livestock ruling

January 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Antibiotics, FDA, Guidelines, Livestock, agriculture, antibiotic resistance, farmers

The FDA began the year by announcing the implementation of ‘Guidance for Industry #213’. The new rule is a voluntary …

Gilead makes move in oncology by snaffling Riva from Novartis

January 4, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Novartis, oncology

Gilead Sciences have made an ambitious move to boost its oncology business by appointing current head of global oncology development …

Giovanni Caforio to be made chairman of the board at BMS

January 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, Giovanni Caforio, bristol myers-squibb

Bristol-Myers Squibb has announced that Giovanni Caforio has been appointed chairman of the board. Caforio will take up the position …

Biogen’s gains late-year drug approval first for controversially expensive drug

January 3, 2017 Manufacturing and Production, Sales and Marketing Biogen, FDA

The FDA squeezed in one last approval before the year ended with the first approval for a drug to treat …

Four die in Seattle Genetics’ drug trial

January 3, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing Seattle Genetics, patient deaths, trial hold

Seattle Genetics released that the FDA had placed a hold had been placed on clinical trials involving its experimental cancer …

Sanofi files lawsuit against Novo Nordisk over ‘false allegations’

January 3, 2017 Manufacturing and Production, Sales and Marketing Novo Nordisk, Sanofi

Sanofi has sued Novo Nordisk over claims made in an advertising campaign for its drug Tresiba. Sanofi has filed the …
The Gateway to Local Adoption Series

Latest content